Cargando…
Protein Glycosylation as Biomarkers in Gynecologic Cancers
Gynecologic cancers are the leading cause of death in women. Endometrial, ovarian, and cervical cancer are the three main types of gynecologic cancers. Poor prognoses and high mortality rates of advanced-stage cancer are still challenges of all three types. Diagnostic tools for early cancer detectio...
Autores principales: | Shen, Hung, Lee, Chia-Yi, Chen, Chi-Hau |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777642/ https://www.ncbi.nlm.nih.gov/pubmed/36553184 http://dx.doi.org/10.3390/diagnostics12123177 |
Ejemplares similares
-
Aberrant glycosylation associated with enzymes as cancer biomarkers
por: Meany, Danni L, et al.
Publicado: (2011) -
Serum Biomarkers for Early Detection of Gynecologic Cancers
por: Ueda, Yutaka, et al.
Publicado: (2010) -
MicroRNAs as Potential Biomarkers in Gynecological Cancers
por: Miśkiewicz, Joanna, et al.
Publicado: (2023) -
Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers
por: Ye, Miaomiao, et al.
Publicado: (2021) -
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics
por: Kirwan, Alan, et al.
Publicado: (2015)